세계의 펜 니들 시장 : 유형별, 바늘 길이별, 유통 채널별 - 기회 분석 및 산업 예측(2023-2032년)

Pen Needles Market By Type, By Needle Length, By Distribution Channel : Global Opportunity Analysis and Industry Forecast, 2023-2032

US $ 5,730 ￦ 8,215,000

PDF (Business License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄는 5회 가능하며, 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 2명 이상이 이용할 경우, 추가 요금을 지불하여 라이선스 업그레이드로 최대 5명까지 이용 가능합니다.

US $ 9,600 ￦ 13,763,000

PDF (Enterprise User License) & Excel (Data Pack) & Free Update

PDF 보고서 및 Excel 데이터를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다. 보고서 업데이트 서비스가 무료로 제공됩니다.

한글목차

펜 니들(Pen Needles) 시장은 의료기기와 소모품 부문 시장 수요 증가로 2023-2032년에 10.3%의 대폭적인 성장률이 전망되고 있습니다.

바늘 끝은 피부에 더 쉽게 침투할 수 있도록 기울어지거나 각진 경우가 많습니다. 주사 시 통증을 더욱 줄이기 위해 주사 바늘에 실리콘과 같은 윤활유를 코팅합니다. 사용 후 펜 니들은 우발적인 부상이나 질병 전파를 방지하기 위해 침 폐기통에 폐기합니다.

펜 니들은 당뇨병, 성장 호르몬 결핍, 불임 등 다양한 유형의 질병에 대한 약물을 투여하는 데 사용됩니다. 펜 니들은 많은 만성 질환을 관리하는 데 중요한 도구이며 정기적인 약물 주사가 필요한 환자의 삶의 질을 개선하는 데 도움이 될 수 있어 수요가 증가하고 있습니다. 또한 당뇨병과 같은 만성 질환의 유병률 증가와 같은 요인도 시장의 주요 추진 요인으로 작용합니다. 예를 들어, 국제 당뇨병 연맹(IDF)은 당뇨병을 앓고 있는 총 인구 수가 2030년까지 6억 4,300만 명, 2045년까지 7억 8,300만 명으로 증가할 것으로 예상한다고 밝혔습니다.

당뇨병은 정기적인 인슐린 주사가 필요한 만성 질환이기 때문에 인슐린 투여에 펜 니들이 일반적으로 사용됩니다. 따라서 전 세계적으로 당뇨병 유병률이 증가함에 따라 펜 니들과 같은 당뇨병 관리 제품에 대한 수요도 동시에 증가할 것으로 예상됩니다.

목차

제1장 서론

제2장 주요 요약

제3장 시장 개요

• 시장 정의 및 범위
• 주요 조사 결과
  • 영향 요인
  • 주요 투자 기회
• Porter's Five Forces 분석
• 시장 역학
  • 성장 촉진 요인
    • 만성 질환 증가
    • 펜 니들의 인지도와 채택률의 급상승
    • 종래의 주사기에 비해 펜 니들이 제공하는 이점
  • 억제 요인
    • 대체 투여 방법의 이용 가능성
    • 펜 니들에 관한 안전성에 대한 우려
  • 기회
    • 펜 니들의 기술적 진보
• COVID-19 시장에 미치는 영향 분석

제4장 펜 니들 시장 : 유형별

• 개요
• 표준 펜 니들
• 안전펜 니들

제5장 펜 니들 시장 : 바늘 길이별

• 개요
• 짧은 바늘
• 중간 바늘
• 긴 바늘

제6장 펜 니들 시장 : 유통 채널별

• 개요
• 병원 약국
• 약국, 소매 약국
• 온라인 제공업체

제7장 펜 니들 시장 : 지역별

• 개요
• 북미
  • 미국
  • 캐나다
  • 멕시코
• 유럽
  • 독일
  • 프랑스
  • 영국
  • 이탈리아
  • 스페인
  • 기타 유럽
• 아시아 태평양
  • 일본
  • 중국
  • 인도
  • 호주
  • 한국
  • 기타 아시아 태평양
• 남미·중동·아프리카
  • 브라질
  • 사우디아라비아
  • 남아프리카공화국
  • 기타 지역

제8장 경쟁 구도

• 소개
• 주요 성공 전략
• 주요 10기업의 제품 매핑
• 경쟁 대시보드
• 경쟁 히트맵
• 주요 기업의 포지셔닝(2022년)

제9장 기업 개요

• Allison Medical Inc.
• B.Braun SE
• Novo Nordisk A/S
• Owen Mumford Ltd.
• Terumo Corporation
• Trividia Health, Inc.
• UltiMed, Inc
• Ypsomed AG
• MTD Medical Technology and Devices SpA
• Embecta Corp.

LYJ

영문 목차

영문목차

The pen needles market is likely to experience a significant growth rate of 10.3% from 2023-2032 owing to increasing market demand from medical devices and supplies sector - Allied Market Research

The tip of the needle is often slanted, or angled, to make it easier to penetrate the skin. It is further coated with a lubricating needle length, such as silicone, to further reduce pain during the injection. After use, the pen needles are disposed of in a sharps container to prevent accidental injury or transmission of disease.

Pen needles are used to administer medication for various types of diseases, including diabetes, growth hormone deficiency, and infertility. Pen needles are an important tool in the management of many chronic conditions and can help improve the quality of life for patients who require regular injections of medication, which is boosting their demand. In addition, factors such as the increase in prevalence of chronic conditions such as diabetes acts as a key driving factor of the market. For instance, the International Diabetes Federation (IDF) stated that the total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045.

As diabetes is a chronic condition that often requires regular insulin injections, pen needles are commonly used for administering insulin. Thus, with the rise in prevalence of diabetes worldwide, the demand for diabetes management products such as pen needles is expected to increase simultaneously.

In addition, rise in awareness about diabetes management, technological advancements in pen needle design, and surge in adoption of injectable drugs for various medical conditions contribute toward the growth of the pen needles market. Injector pens are designed to be used with specific types of pen needles, and as more people become aware of the benefits of using injector pens, the demand for compatible pen needles is anticipated to increase concurrently, thereby driving the growth of the market.

Furthermore, pen needles exhibit ultra-thin wall construction, which allows for a larger inner diameter while maintaining the same outer diameter. This can improve the flow rate and reduce the injection time. Moreover, some pen needles have safety features, such as a protective shield or cap, to prevent accidental injury after use. The availability of pen needles in different sizes, lengths, and gauges makes it possible to customize the injection to the individual's needs, which can help to improve medication absorption and reduce discomfort during the injection.

Furthermore, injector pens are used for administering a variety of medications, including growth hormone, fertility drugs, and other biologic drugs. As more people become aware of the benefits of using injector pens for these medical treatments, the demand for compatible pen needles is expected to increase, which contributes to the market growth. However, safety concerns related to needlestick injuries and contamination can be a significant restraint of the pen needle market.

Needlestick injuries can occur when healthcare workers or patients accidentally prick themselves with a needle, which can lead to the transmission of blood-borne infections. This is a significant safety concern for healthcare workers who are routinely exposed to needles and other sharp instruments.

On the contrary, to address the safety concerns related to needlestick injuries and contamination, several key players in the pen needle market have developed safety pen needles that offer advantages over standard needles. Some safety pen needles are designed with a needle shielding feature that covers the needle after use, which can further reduce the risk of accidental needlestick injuries. As people are becoming aware about safety needles, the demand for safety needles is anticipated to rise in the coming years, which will augment the market growth.

In addition, emerging countries in Asia-Pacific and LAMEA present lucrative opportunities for key players looking to invest in the pen needles market. This is attributed to the fact that these regions are characterized by the presence of a large population base with strong economic growth and increase in healthcare expenditure. In addition, an alarming rise in prevalence of diabetes in these regions along with an increase in awareness regarding injector pens is anticipated to drive the market growth.

The global pen needles market is segmented into type, needle length, distribution channel, and region. By type, the market is categorized into standard pen needles and safety pen needles. Based on needle length, it is segregated into short length pen needles, medium length pen needles, and long length pen needles. Based on distribution channel, it is divided into hospital pharmacies, drug stores & retail pharmacies, and online providers.

Region wise, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA). Major players that operate in the market include Allison Medical, B.Braun SE, Embecta Corp., MTD Medical Technology and Devices S.p.A, Novo Nordisk A/S, Owen Mumford Ltd, Terumo Corporation, Trividia Health, Inc., UltiMed, Inc., and Ypsomed AG.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the pen needles market analysis from 2022 to 2032 to identify the prevailing pen needles market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the pen needles market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global pen needles market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Type

• Standard Pen Needles
• Safety Pen Needles

By Needle Length

• Short Length Pen Needles
• Medium Length Pen Needles
• Long Length Pen Needles

By Distribution Channel

• Hospital Pharmacies
• Drug Stores and Retail Pharmacies
• Online Providers

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • Japan
  • China
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • South Africa
  • Rest of LAMEA

Key Market Players:

• Allison Medical Inc.
• B.Braun SE
• Embecta Corp.
• MTD Medical Technology and Devices S.p.A
• Novo Nordisk A/S
• Owen Mumford Ltd.
• Terumo Corporation
• Trividia Health, Inc.
• UltiMed, Inc
• Ypsomed AG

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report description
• 1.2. Key market segments
• 1.3. Key benefits to the stakeholders
• 1.4. Research Methodology
  • 1.4.1. Primary research
  • 1.4.2. Secondary research
  • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

• 3.1. Market definition and scope
• 3.2. Key findings
  • 3.2.1. Top impacting factors
  • 3.2.2. Top investment pockets
• 3.3. Porter's five forces analysis
  • 3.3.1. High bargaining power of suppliers
  • 3.3.2. Moderate threat of new entrants
  • 3.3.3. Moderate threat of substitutes
  • 3.3.4. Moderate intensity of rivalry
  • 3.3.5. High bargaining power of buyers
• 3.4. Market dynamics
  • 3.4.1. Drivers
    • 3.4.1.1. Increase in prevalence of chronic conditions
    • 3.4.1.2. Surge in awareness and adoption of injector pens
    • 3.4.1.3. Advantages offered by pen needles over traditional syringes

• 3.4.2. Restraints
  • 3.4.2.1. Availability of alternative modes of delivery
  • 3.4.2.2. Safety concerns regarding pen needles

• 3.4.3. Opportunities
  • 3.4.3.1. Technological advancements in pen needles

• 3.5. COVID-19 Impact Analysis on the market

CHAPTER 4: PEN NEEDLES MARKET, BY TYPE

• 4.1. Overview
  • 4.1.1. Market size and forecast
• 4.2. Standard Pen Needles
  • 4.2.1. Key market trends, growth factors and opportunities
  • 4.2.2. Market size and forecast, by region
  • 4.2.3. Market share analysis by country
• 4.3. Safety Pen Needles
  • 4.3.1. Key market trends, growth factors and opportunities
  • 4.3.2. Market size and forecast, by region
  • 4.3.3. Market share analysis by country

CHAPTER 5: PEN NEEDLES MARKET, BY NEEDLE LENGTH

• 5.1. Overview
  • 5.1.1. Market size and forecast
• 5.2. Short Length Pen Needles
  • 5.2.1. Key market trends, growth factors and opportunities
  • 5.2.2. Market size and forecast, by region
  • 5.2.3. Market share analysis by country
• 5.3. Medium Length Pen Needles
  • 5.3.1. Key market trends, growth factors and opportunities
  • 5.3.2. Market size and forecast, by region
  • 5.3.3. Market share analysis by country
• 5.4. Long Length Pen Needles
  • 5.4.1. Key market trends, growth factors and opportunities
  • 5.4.2. Market size and forecast, by region
  • 5.4.3. Market share analysis by country

CHAPTER 6: PEN NEEDLES MARKET, BY DISTRIBUTION CHANNEL

• 6.1. Overview
  • 6.1.1. Market size and forecast
• 6.2. Hospital Pharmacies
  • 6.2.1. Key market trends, growth factors and opportunities
  • 6.2.2. Market size and forecast, by region
  • 6.2.3. Market share analysis by country
• 6.3. Drug Stores and Retail Pharmacies
  • 6.3.1. Key market trends, growth factors and opportunities
  • 6.3.2. Market size and forecast, by region
  • 6.3.3. Market share analysis by country
• 6.4. Online Providers
  • 6.4.1. Key market trends, growth factors and opportunities
  • 6.4.2. Market size and forecast, by region
  • 6.4.3. Market share analysis by country

CHAPTER 7: PEN NEEDLES MARKET, BY REGION

• 7.1. Overview
  • 7.1.1. Market size and forecast By Region
• 7.2. North America
  • 7.2.1. Key trends and opportunities
  • 7.2.2. Market size and forecast, by Type
  • 7.2.3. Market size and forecast, by Needle Length
  • 7.2.4. Market size and forecast, by Distribution Channel
  • 7.2.5. Market size and forecast, by country
    • 7.2.5.1. U.S.
    • 7.2.5.1.1. Key market trends, growth factors and opportunities
    • 7.2.5.1.2. Market size and forecast, by Type
    • 7.2.5.1.3. Market size and forecast, by Needle Length
    • 7.2.5.1.4. Market size and forecast, by Distribution Channel
    • 7.2.5.2. Canada
    • 7.2.5.2.1. Key market trends, growth factors and opportunities
    • 7.2.5.2.2. Market size and forecast, by Type
    • 7.2.5.2.3. Market size and forecast, by Needle Length
    • 7.2.5.2.4. Market size and forecast, by Distribution Channel
    • 7.2.5.3. Mexico
    • 7.2.5.3.1. Key market trends, growth factors and opportunities
    • 7.2.5.3.2. Market size and forecast, by Type
    • 7.2.5.3.3. Market size and forecast, by Needle Length
    • 7.2.5.3.4. Market size and forecast, by Distribution Channel
• 7.3. Europe
  • 7.3.1. Key trends and opportunities
  • 7.3.2. Market size and forecast, by Type
  • 7.3.3. Market size and forecast, by Needle Length
  • 7.3.4. Market size and forecast, by Distribution Channel
  • 7.3.5. Market size and forecast, by country
    • 7.3.5.1. Germany
    • 7.3.5.1.1. Key market trends, growth factors and opportunities
    • 7.3.5.1.2. Market size and forecast, by Type
    • 7.3.5.1.3. Market size and forecast, by Needle Length
    • 7.3.5.1.4. Market size and forecast, by Distribution Channel
    • 7.3.5.2. France
    • 7.3.5.2.1. Key market trends, growth factors and opportunities
    • 7.3.5.2.2. Market size and forecast, by Type
    • 7.3.5.2.3. Market size and forecast, by Needle Length
    • 7.3.5.2.4. Market size and forecast, by Distribution Channel
    • 7.3.5.3. UK
    • 7.3.5.3.1. Key market trends, growth factors and opportunities
    • 7.3.5.3.2. Market size and forecast, by Type
    • 7.3.5.3.3. Market size and forecast, by Needle Length
    • 7.3.5.3.4. Market size and forecast, by Distribution Channel
    • 7.3.5.4. Italy
    • 7.3.5.4.1. Key market trends, growth factors and opportunities
    • 7.3.5.4.2. Market size and forecast, by Type
    • 7.3.5.4.3. Market size and forecast, by Needle Length
    • 7.3.5.4.4. Market size and forecast, by Distribution Channel
    • 7.3.5.5. Spain
    • 7.3.5.5.1. Key market trends, growth factors and opportunities
    • 7.3.5.5.2. Market size and forecast, by Type
    • 7.3.5.5.3. Market size and forecast, by Needle Length
    • 7.3.5.5.4. Market size and forecast, by Distribution Channel
    • 7.3.5.6. Rest of Europe
    • 7.3.5.6.1. Key market trends, growth factors and opportunities
    • 7.3.5.6.2. Market size and forecast, by Type
    • 7.3.5.6.3. Market size and forecast, by Needle Length
    • 7.3.5.6.4. Market size and forecast, by Distribution Channel
• 7.4. Asia-Pacific
  • 7.4.1. Key trends and opportunities
  • 7.4.2. Market size and forecast, by Type
  • 7.4.3. Market size and forecast, by Needle Length
  • 7.4.4. Market size and forecast, by Distribution Channel
  • 7.4.5. Market size and forecast, by country
    • 7.4.5.1. Japan
    • 7.4.5.1.1. Key market trends, growth factors and opportunities
    • 7.4.5.1.2. Market size and forecast, by Type
    • 7.4.5.1.3. Market size and forecast, by Needle Length
    • 7.4.5.1.4. Market size and forecast, by Distribution Channel
    • 7.4.5.2. China
    • 7.4.5.2.1. Key market trends, growth factors and opportunities
    • 7.4.5.2.2. Market size and forecast, by Type
    • 7.4.5.2.3. Market size and forecast, by Needle Length
    • 7.4.5.2.4. Market size and forecast, by Distribution Channel
    • 7.4.5.3. India
    • 7.4.5.3.1. Key market trends, growth factors and opportunities
    • 7.4.5.3.2. Market size and forecast, by Type
    • 7.4.5.3.3. Market size and forecast, by Needle Length
    • 7.4.5.3.4. Market size and forecast, by Distribution Channel
    • 7.4.5.4. Australia
    • 7.4.5.4.1. Key market trends, growth factors and opportunities
    • 7.4.5.4.2. Market size and forecast, by Type
    • 7.4.5.4.3. Market size and forecast, by Needle Length
    • 7.4.5.4.4. Market size and forecast, by Distribution Channel
    • 7.4.5.5. South Korea
    • 7.4.5.5.1. Key market trends, growth factors and opportunities
    • 7.4.5.5.2. Market size and forecast, by Type
    • 7.4.5.5.3. Market size and forecast, by Needle Length
    • 7.4.5.5.4. Market size and forecast, by Distribution Channel
    • 7.4.5.6. Rest of Asia-Pacific
    • 7.4.5.6.1. Key market trends, growth factors and opportunities
    • 7.4.5.6.2. Market size and forecast, by Type
    • 7.4.5.6.3. Market size and forecast, by Needle Length
    • 7.4.5.6.4. Market size and forecast, by Distribution Channel
• 7.5. LAMEA
  • 7.5.1. Key trends and opportunities
  • 7.5.2. Market size and forecast, by Type
  • 7.5.3. Market size and forecast, by Needle Length
  • 7.5.4. Market size and forecast, by Distribution Channel
  • 7.5.5. Market size and forecast, by country
    • 7.5.5.1. Brazil
    • 7.5.5.1.1. Key market trends, growth factors and opportunities
    • 7.5.5.1.2. Market size and forecast, by Type
    • 7.5.5.1.3. Market size and forecast, by Needle Length
    • 7.5.5.1.4. Market size and forecast, by Distribution Channel
    • 7.5.5.2. Saudi Arabia
    • 7.5.5.2.1. Key market trends, growth factors and opportunities
    • 7.5.5.2.2. Market size and forecast, by Type
    • 7.5.5.2.3. Market size and forecast, by Needle Length
    • 7.5.5.2.4. Market size and forecast, by Distribution Channel
    • 7.5.5.3. South Africa
    • 7.5.5.3.1. Key market trends, growth factors and opportunities
    • 7.5.5.3.2. Market size and forecast, by Type
    • 7.5.5.3.3. Market size and forecast, by Needle Length
    • 7.5.5.3.4. Market size and forecast, by Distribution Channel
    • 7.5.5.4. Rest of LAMEA
    • 7.5.5.4.1. Key market trends, growth factors and opportunities
    • 7.5.5.4.2. Market size and forecast, by Type
    • 7.5.5.4.3. Market size and forecast, by Needle Length
    • 7.5.5.4.4. Market size and forecast, by Distribution Channel

CHAPTER 8: COMPETITIVE LANDSCAPE

• 8.1. Introduction
• 8.2. Top winning strategies
• 8.3. Product Mapping of Top 10 Player
• 8.4. Competitive Dashboard
• 8.5. Competitive Heatmap
• 8.6. Top player positioning, 2022

CHAPTER 9: COMPANY PROFILES

• 9.1. Allison Medical Inc.
  • 9.1.1. Company overview
  • 9.1.2. Key Executives
  • 9.1.3. Company snapshot
  • 9.1.4. Operating business segments
  • 9.1.5. Product portfolio
• 9.2. B.Braun SE
  • 9.2.1. Company overview
  • 9.2.2. Key Executives
  • 9.2.3. Company snapshot
  • 9.2.4. Operating business segments
  • 9.2.5. Product portfolio
  • 9.2.6. Business performance
• 9.3. Novo Nordisk A/S
  • 9.3.1. Company overview
  • 9.3.2. Key Executives
  • 9.3.3. Company snapshot
  • 9.3.4. Operating business segments
  • 9.3.5. Product portfolio
  • 9.3.6. Business performance
• 9.4. Owen Mumford Ltd.
  • 9.4.1. Company overview
  • 9.4.2. Key Executives
  • 9.4.3. Company snapshot
  • 9.4.4. Operating business segments
  • 9.4.5. Product portfolio
• 9.5. Terumo Corporation
  • 9.5.1. Company overview
  • 9.5.2. Key Executives
  • 9.5.3. Company snapshot
  • 9.5.4. Operating business segments
  • 9.5.5. Product portfolio
  • 9.5.6. Business performance
  • 9.5.7. Key strategic moves and developments
• 9.6. Trividia Health, Inc.
  • 9.6.1. Company overview
  • 9.6.2. Key Executives
  • 9.6.3. Company snapshot
  • 9.6.4. Operating business segments
  • 9.6.5. Product portfolio
• 9.7. UltiMed, Inc
  • 9.7.1. Company overview
  • 9.7.2. Key Executives
  • 9.7.3. Company snapshot
  • 9.7.4. Operating business segments
  • 9.7.5. Product portfolio
  • 9.7.6. Key strategic moves and developments
• 9.8. Ypsomed AG
  • 9.8.1. Company overview
  • 9.8.2. Key Executives
  • 9.8.3. Company snapshot
  • 9.8.4. Operating business segments
  • 9.8.5. Product portfolio
  • 9.8.6. Business performance
  • 9.8.7. Key strategic moves and developments
• 9.9. MTD Medical Technology and Devices S.p.A
  • 9.9.1. Company overview
  • 9.9.2. Key Executives
  • 9.9.3. Company snapshot
  • 9.9.4. Operating business segments
  • 9.9.5. Product portfolio
• 9.10. Embecta Corp.
  • 9.10.1. Company overview
  • 9.10.2. Key Executives
  • 9.10.3. Company snapshot
  • 9.10.4. Operating business segments
  • 9.10.5. Product portfolio
  • 9.10.6. Business performance
  • 9.10.7. Key strategic moves and developments

관련자료